Implantation of engineered human microvasculature to study human infectious diseases in mouse models
暂无分享,去创建一个
L. Muller | X. Nassif | T. Guilbert | Julie Meyer | C. Chaussain | Jean-Philippe Barnier | Mathieu Coureuil | C. Gorin | S. Schönherr-Hellec | E. Chatzopoulou | Y. Atlas | Sébastien Dupichaud | S. Germain | Yves Dupraz
[1] Jeong Ah Kim,et al. Prevention of collagen hydrogel contraction using polydopamine-coating and alginate outer shell increases cell contractile force. , 2022, Biomaterials advances.
[2] D. Nuzzo,et al. The Role of Endothelium in COVID-19 , 2021, International journal of molecular sciences.
[3] Kevin Maringer,et al. The emerging role of perivascular cells (pericytes) in viral pathogenesis , 2021, The Journal of general virology.
[4] I. Richard,et al. Return-to-work, disabilities and occupational health in the age of COVID-19 , 2021, Scandinavian journal of work, environment & health.
[5] S. Bourdoulous,et al. Type IV pilus retraction enables sustained bacteremia and plays a key role in the outcome of meningococcal sepsis in a humanized mouse model , 2021, PLoS pathogens.
[6] P. Bruneval,et al. Colonization of dermal arterioles by Neisseria meningitidis provides a safe haven from neutrophils , 2021, Nature Communications.
[7] S. Germain,et al. Microvascular maturation by mesenchymal stem cells in vitro improves blood perfusion in implanted tissue constructs. , 2020, Biomaterials.
[8] C. Bult,et al. Innovations, challenges, and minimal information for standardization of humanized mice , 2020, EMBO molecular medicine.
[9] P. Carmeliet,et al. COVID-19: the vasculature unleashed , 2020, Nature Reviews Immunology.
[10] Martin Stahl,et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.
[11] L. Thurlow,et al. Development of humanized mouse and rat models with full-thickness human skin and autologous immune cells , 2020, Scientific Reports.
[12] S. Bourdoulous,et al. Strategies used by bacterial pathogens to cross the blood–brain barrier , 2020, Cellular microbiology.
[13] S. Marullo,et al. Sialic acid mediated mechanical activation of β2 adrenergic receptors by bacterial pili , 2019, Nature Communications.
[14] A. Craig,et al. Developing a xenograft model of human vasculature in the mouse ear pinna , 2019, Scientific Reports.
[15] B. Maier,et al. Type IV pili: dynamics, biophysics and functional consequences , 2019, Nature Reviews Microbiology.
[16] C. Hunter,et al. Pathogen interactions with endothelial cells and the induction of innate and adaptive immunity , 2018, European journal of immunology.
[17] A. M. Ortega-Prieto,et al. A Hitchhiker's guide to humanized mice: new pathways to studying viral infections , 2018, Immunology.
[18] T. Rattei,et al. Peripheral blood vessels are a niche for blood-borne meningococci , 2017, Virulence.
[19] S. Bourdoulous,et al. A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers , 2017, Nature Reviews Microbiology.
[20] P. Merlet,et al. Priming Dental Pulp Stem Cells With Fibroblast Growth Factor‐2 Increases Angiogenesis of Implanted Tissue‐Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion , 2016, Stem cells translational medicine.
[21] Yuejun Kang,et al. Simple surface engineering of polydimethylsiloxane with polydopamine for stabilized mesenchymal stem cell adhesion and multipotency , 2015, Scientific Reports.
[22] S. Germain,et al. The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis , 2015, Science Signaling.
[23] X. Nassif,et al. Meningococcal interaction to microvasculature triggers the tissular lesions of purpura fulminans. , 2013, The Journal of infectious diseases.
[24] P. Bruneval,et al. Adhesion of Neisseria meningitidis to Dermal Vessels Leads to Local Vascular Damage and Purpura in a Humanized Mouse Model , 2013, PLoS pathogens.
[25] M. Vacher-Lavenu,et al. Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] R. Jain,et al. Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. , 2011, Blood.
[27] Holger Weber,et al. Spheroid-based human endothelial cell microvessel formation in vivo , 2009, Nature Protocols.
[28] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[29] Ash A. Alizadeh,et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock , 2004, The Lancet.
[30] Stan Gronthos,et al. SHED: Stem cells from human exfoliated deciduous teeth , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] X. Nassif,et al. Interaction of Neisseria maningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC. , 1997, The Journal of infectious diseases.
[32] R. Sauerwein,et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. , 1995, The Journal of infectious diseases.
[33] T. Rudel,et al. Neisseria PilC protein identified as type-4 pilus tip-located adhesin , 1995, Nature.
[34] X. Nassif,et al. Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells , 1993, Molecular microbiology.
[35] M. Herlyn,et al. Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. , 1993, The Journal of clinical investigation.
[36] P. Brandtzaeg,et al. Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .